Evidence-based assessment/Process phase
Squid Game 2 had 68 million viewers on its launch -- that is a lot of people who might benefit from resources organized by themes in each episode. Check out this resource built by a team supported in part by a WMF Rapid Grant after season 1!
~ More at HGAPS.org ~
|
Medical disclaimer: This page is for educational and informational purposes only and may not be construed as medical advice. The information is not intended to replace medical advice offered by physicians. Please refer to the full text of the Wikiversity medical disclaimer. |
Process, Progress, and Outcome Phase
editOverview
editMeasuring process, progress, and outcome helps make adjustments over the course of therapy, often improving outcomes. Process refers to ways of looking at treatment mediators, and also measures of engagement, adherence, and fidelity. Progress refers to tracking change on target measures, typically measured with more brief and frequently repeated tools than used at other assessment stages. Outcome measures can include tools with predefined benchmarks or a priori definitions of reliable improvement or worsening. All of these are described in more detail below.
Rationale
editThe primary goal at this phase of assessment is to improve patient outcomes.
Process Measures
editProgress Measures
editOutcome Measures
editOutcome measures are tools to document progress towards major goals in treatment. In clinical trials, these are often symptom severity measures based on interviews, and the average scores are compared for groups receiving different treatments (e.g., cognitive-behavioral therapy versus antidepressant, or dialectical behavioral-therapy versus treatment as usual), or comparing the average at the end of treatment to the average at baseline.
These tests are looking at the average outcome. There usually is a wide range of individual scenarios, though. Some people get much better than typical outcomes, some do less well, and some cases may actually get worse over the course of treatment. Clinical significance is a way of looking at an individual's outcome, and deciding whether treatment produced meaningful benefit. All of the different techniques within the "clinical significance" set focus on each individual case, rather than the group average.
Here's a link to a tool that shows the reliable change index and the A, B, C benchmarks for several widely used measures with youths. It includes some interactive graphics that may help visualize the comparisons with the clinical and nonclinical groups to see where the individual case falls.
Steps to put into practice
editWays of evaluating change
Visualization Methods
editThere are many ways of charting or visualizing change over time to get a sense of progress. These include line charts, dot plots, Brinley plots, and others.
Annotated bibliography
edit
Tables and figures
editClinically significant change benchmarks for widely-used outcome measures
edit- Click here for a set of slides explaining clinically significant change: Improving Diagnosis & Documenting Clinically Significant Change
- More research on clinically significant change: Establishing Clinical Significance Benchmarks and Minimally Important Difference for 17 Measures
| Benchmarks Based on Published Norms | ||||||||
| Measure | Subscale | Cut-off scores | Critical Change
(unstandardized scores) |
MID (d 0.5) | ||||
| A | B | C | 95% | 90% | SEdifference | |||
| Beck Depression Inventory[1] | BDI Mixed Depression | 4 | 22 | 15 | 9 | 8 | 4.8 | 3.4 |
| CBCL T-scores
(2001 Norms) |
Total | 49 | 70 | 58 | 5 | 4 | 2.4 | - |
|---|---|---|---|---|---|---|---|---|
| Externalizing | 49 | 70 | 58 | 7 | 6 | 3.4 | - | |
| Internalizing | n/a | 70 | 56 | 9 | 7 | 4.5 | - | |
| Attention Problems | n/a | 66 | 58 | 8 | 7 | 4.2 | - | |
| CBCL T-scores
Age 1 1/2 - 5 (2001 Norms) |
Total | 42.9 | 71.2 | 56.3 | 4.8 | 4.1 | 2.5 | 4.1 |
| Externalizing | 41.5 | 70.8 | 56.5 | 5.7 | 4.8 | 2.9 | 4.8 | |
| Internalizing | 40.1 | 70.9 | 54.4 | 9.1 | 7.6 | 4.6 | 7.6 | |
| Attention Problems | 40.0 | 67.3 | 57.1 | 7.6 | 6.4 | 3.9 | 6.4 | |
| CBCL T-scores
Age 6 - 11 (Male/Female) (2001 Norms) |
Male Total | 49.1 | 69.3 | 59.2 | 4.5 | 3.8 | 2.3 | 4.7 |
| Female Total | 43.3 | 68.6 | 57.1 | 4.6 | 3.9 | 2.4 | 4.9 | |
| Male Externalizing | 49.1 | 68.9 | 59.3 | 6.4 | 5.4 | 3.3 | 4.7 | |
| Female Externalizing | 42.5 | 68.0 | 57.4 | 6.6 | 5.6 | 3.4 | 5.0 | |
| Male Internalizing | 42.6 | 69.3 | 56.4 | 8.7 | 7.3 | 4.4 | 5.0 | |
| Female Internalizing | 36.2 | 69.0 | 54.6 | 9.4 | 7.9 | 4.8 | 5.5 | |
| Male Attention Problems | 45.4 | 65.2 | 58.7 | 7.8 | 6.6 | 4.0 | 6.6 | |
| Female Attention Problems | 41.8 | 66.1 | 58.5 | 8.1 | 6.8 | 4.1 | 6.8 | |
| CBCL T-scores
Age 12 - 18 (Male/Female) (2001 Norms) |
Male Total | 46.8 | 69.3 | 58.2 | 4.4 | 3.7 | 2.2 | 4.6 |
| Female Total | 47.0 | 69.3 | 58.3 | 4.5 | 3.8 | 2.3 | 4.7 | |
| Male Externalizing | 45.8 | 69.4 | 58.1 | 6.4 | 5.4 | 3.3 | 4.8 | |
| Female Externalizing | 44.0 | 69.0 | 57.4 | 6.5 | 5.5 | 3.3 | 4.8 | |
| Male Internalizing | 42.2 | 69.6 | 56.6 | 8.4 | 7.1 | 4.3 | 4.8 | |
| Female Internalizing | 43.9 | 69.2 | 57.3 | 8.5 | 7.1 | 4.3 | 4.9 | |
| Male Attention Problems | 43.9 | 66.0 | 58.3 | 7.8 | 6.5 | 4.0 | 6.5 | |
| Female Attention Problems | 43.6 | 65.2 | 58.0 | 7.9 | 6.6 | 4.0 | 6.6 | |
| TRF T-scores
(2001 Norms) |
Total | n/a | 70 | 57 | 5 | 4 | 2.3 | - |
| Externalizing | n/a | 70 | 56 | 6 | 5 | 3.0 | - | |
| Internalizing | n/a | 70 | 55 | 9 | 7 | 4.4 | - | |
| Attention Problems | n/a | 66 | 57 | 5 | 4 | 4.8 | - | |
| C-TRF T-scores
Age 1 1/2 - 5 (2001 Norms) |
Total | 42.9 | 71.2 | 56.3 | 4.8 | 4.1 | 2.5 | - |
| Externalizing | 41.5 | 70.8 | 56.5 | 5.7 | 4.8 | 2.9 | - | |
| Internalizing | 40.1 | 70.9 | 54.4 | 9.1 | 7.6 | 4.6 | - | |
| TRF T-scores
Age 6 - 11 (Male/Female) (2001 Norms) |
Male Total | 43.7 | 70.2 | 56.6 | 4.7 | 3.9 | 2.4 | 3.9 |
| Female Total | 42.1 | 69.8 | 55.8 | 4.7 | 3.9 | 2.4 | 3.9 | |
| Male Externalizing | 43.4 | 67.9 | 56.9 | 5.1 | 4.3 | 2.6 | 4.3 | |
| Female Externalizing | 37.8 | 67.7 | 54.5 | 5.9 | 5.0 | 3.0 | 5.0 | |
| Male Internalizing | 36.8 | 69.9 | 54.5 | 8.9 | 7.5 | 4.6 | 7.5 | |
| Female Internalizing | 36.8 | 70.1 | 53.9 | 8.7 | 7.3 | 4.4 | 7.3 | |
| Male Attention Problems | 44.3 | 66.2 | 57.1 | 4.4 | 3.7 | 2.3 | 3.7 | |
| Female Attention Problems | 43.2 | 65.8 | 57.3 | 4.6 | 3.9 | 2.4 | 3.9 | |
| TRF T-scores
Age 12 - 18 (Male/Female) (2001 Norms) |
Male Total | 46.1 | 70.4 | 57.2 | 4.4 | 3.7 | 2.3 | 3.7 |
| Female Total | 47.5 | 70.3 | 58.0 | 4.5 | 3.7 | 2.3 | 3.7 | |
| Male Externalizing | 45.3 | 68.5 | 57.9 | 5.2 | 4.3 | 2.6 | 4.3 | |
| Female Externalizing | 41.7 | 68.1 | 56.2 | 5.9 | 4.9 | 3.0 | 4.9 | |
| Male Internalizing | 41.6 | 69.4 | 55.5 | 8.2 | 6.9 | 4.2 | 6.9 | |
| Female Internalizing | 41.8 | 69.0 | 55.8 | 8.2 | 6.9 | 4.2 | 6.9 | |
| Male Attention Problems | 43.2 | 67.6 | 57.1 | 4.7 | 4.0 | 2.4 | 4.0 | |
| Female Attention Problems | 45.5 | 66.8 | 58.1 | 4.6 | 3.9 | 2.4 | 3.9 | |
| YSR T-scores
(2001 Norms) |
Total | n/a | 70 | 54 | 7 | 6 | 3.3 | - |
| Externalizing | n/a | 70 | 54 | 9 | 8 | 4.6 | - | |
| Internalizing | n/a | 70 | 54 | 9 | 8 | 4.8 | - | |
| YSR T-scores
Age 11 - 18 (2001 Norms) |
Male Total | 35.3 | 69.8 | 54.0 | 6.7 | 5.6 | 3.4 | 5.6 |
| Female Total | 36.8 | 69.8 | 54.1 | 6.4 | 5.4 | 3.3 | 5.4 | |
| Male Externalizing | 38.3 | 69.3 | 54.6 | 8.9 | 7.5 | 4.6 | 7.5 | |
| Female Externalizing | 35.7 | 70.2 | 53.8 | 9.2 | 7.8 | 4.7 | 7.8 | |
| Male Internalizing | 32.7 | 69.9 | 53.2 | 9.6 | 8.1 | 4.9 | 8.1 | |
| Female Internalizing | 35.6 | 70.2 | 53.8 | 9.3 | 7.8 | 4.8 | 7.8 | |
| Male Attention Problems | 38.6 | 67.1 | 56.6 | 10.5 | 8.8 | 5.3 | 8.8 | |
| Female Attention Problems | 39.8 | 65.8 | 56.2 | 9.5 | 8.0 | 4.8 | 8.0 | |
| Benchmarks Based on Published Norms | ||||||||
| Measures | Subscale | Age | Cut-off scores | Critical Change
(unstandardized scores) | ||||
| A | B | C | 95% | 90% | SEdifference | |||
| CBCL (Raw Scores) | Total | Male 6-11 | 3.8 | 57.1 | 39 | 11.1 | 9.3 | 5.7 |
| Male 12-17 | 1.7 | 63 | 40 | 11.6 | 9.8 | 5.9 | ||
| Female 6-11 | - | 55.1 | 35 | 10.7 | 9 | 5.5 | ||
| Female 12-17 | - | 58.2 | 37 | 11.6 | 9.7 | 5.9 | ||
| TRF (Raw Scores) | Total | Male 6-11 | - | 70.1 | 38 | 13 | 11 | 6.6 |
| Male 12-17 | - | 75.4 | 40 | 14 | 11.8 | 7.2 | ||
| Female 6-11 | - | 55.1 | 27 | 11.7 | 9.9 | 6 | ||
| Female 12-17 | - | 54.6 | 29 | 12 | 10.1 | 6.1 | ||
| YSR (Raw Scores) | Total | Male 11-18 | - | 113 | 54 | 18.3 | 15.4 | 9.3 |
| Female 11-18 | 1 | 117 | 59 | 18 | 15.2 | 9.2 | ||
| Beck Depression Inventory | Mixed Depression | 13-80 | 4 | 22 | 15 | 9 | 8 | 4.8 |
| PGBI-10M | Total | 5-18 | 1 | 9 | 6 | 6 | 5 | 3.2 |
| CMRS 10 | Total | 5-18 | -- | 6 | 4 | 5 | 4 | 2.3 |
| PGBI-10Da | Total | 5-18 | -- | 7 | 4 | 6 | 5 | 3.0 |
| PGBI-10Db | Total | 5-18 | -- | 7 | 4 | 6 | 5 | 2.9 |
| AGBI-10M | Total | 11-90 | -- | 14 | 7 | 6 | 5 | 3.1 |
| AGBI-10Da | Total | 11-90 | -- | 18 | 7 | 6 | 5 | 3.2 |
| AGBI-10Db | Total | 11-90 | -- | 16 | 7 | 6 | 5 | 2.9 |
| 7 Up | Total | 11-90 | -- | 8 | 4 | 4 | 4 | 2.2 |
| 7 Down | Total | 11-90 | -- | 12 | 5 | 5 | 4 | 2.3 |
| KMRS | Total | 5-18 | 19 | 19 | 19 | 3 | 3 | 1.6 |
| KDRS | Total | 5-18 | 12 | 19 | 18 | 5 | 4 | 2.4 |
| CDRS-R Total | Total | 5-18+ | -- | 24 | 22 | 6 | 5 | 2.9 |
| YMRS Total | Total | 5-90 | 4 | 3 | 3 | 3 | 3 | 1.8 |
| Measure | Symptom Domain | Subscale | Cut-off scores | Critical Change (Unstandardized scores) | MID (d .5) | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Acronym | Full Name | A | B | C | 95% | 90% | SE Difference | |||
| 7PS | 7-Item Psychosis Screener | Psychosis | Distress | |||||||
| Total | ||||||||||
| A-ASWS | Abbreviated Adolescent Sleep Wake Scale | Sleep | Falling Asleep and Reinitiating Sleep | 3.88 | 4.74 | |||||
| Returning to Wakefulness | 2.44 | 3.28 | ||||||||
| Going to bed | 3.93 | 3.66 | ||||||||
| AAQ-II | Acceptance and Action Questionnaire-II | Anxiety | Total | 8.5 | 32.61 | 22.59 | 9.27 | 7.81 | 4.73 | 4.30 |
| ADHD-RS-IV | ADHD Rating Scale-IV | ADHD | Inattention (Parent) | 9.54 | 15.34 | 12.44 | 4.85 | 4.08 | 2.47 | 2.34 |
| Hyperactivity/Impulsivity (Parent) | 4.62 | 17.68 | 11.76 | 5.42 | 4.56 | 2.76 | 2.85 | |||
| Inattention (Teacher) | 7.25 | 0.36 | ||||||||
| Hyperactivity/Impulsivity (Teacher) | 7.17 | 0.45 | ||||||||
| AIMS | Abnormal Involuntary Movement Scale | Total | 1.50 | 3.00 | 2.60 | 5.52 | 4.64 | 2.81 | 1.24 | |
| AQ-10 | Autism Spectrum Quotient | Autism | Child | 5.78 | 4.95 | 5.38 | 1.31 | 1.11 | 0.67 | 0.75 |
| Adolescent | 5.02 | 5.38 | 5.19 | 1.60 | 1.35 | 0.82 | 0.87 | |||
| Adult | 4.97 | 6.77 | 5.40 | 2.11 | 1.78 | 1.08 | 0.98 | |||
| ASQ | Ask Suicide-Screening Questions | Self Injury | Total | |||||||
| ASRS | Adult ADHD Self-Report Scale (ASRS) | ADHD | Total | -4.4 | 1.13 | |||||
| BCMRS | Brief Child Mania Rating Scale | Bipolar/Mania | Total | 4.57 | 10.74 | 7.86 | 5.55 | 4.67 | 2.83 | 2.37 |
| BFCSI | Bush-Francis Catatonia Screening Instrument | Schizophrenia | Total | -9.71 | 1.73 | |||||
| BFCRS | Bush-Francis Catatonia Rating Scale | Scizophrenia | Total | -18.92 | 3.50 | |||||
| BIS-11 | Barratt Impulsiveness Scale | Risk/Impulsiveness | Attentional | 24.9 | 1.45 | |||||
| Motor | 30 | 1.41 | ||||||||
| Nonplanning | 33.4 | 1.73 | ||||||||
| Overall | 46.15 | 82.9 | 66.38 | 13.02 | 10.96 | 6.65 | 5.76 | |||
| CAS | Clinical Anger Scale | Conduct Problems | Male | 31.01 | 3.61 | |||||
| Female | 25.52 | 2.86 | ||||||||
| Total | 27.11 | 3.08 | ||||||||
| CAST | Childhood Autism Spectrum Test | Autism | Total | 10.06 | 11.87 | 11.16 | 12.29 | 10.39 | 6.27 | 2.32 |
| CHRT | Concise Health Risk Tracking Scale | Self Injury | Propensity | 0.60 | 3.68 | |||||
| Risk/suicidal thoughts | -3.00 | 0.78 | ||||||||
| COIS-R | Child Obsessive-Compulsive Impact Scale - Revised | OCD | Parent Version - School | -4.5 | 1.73 | |||||
| Parent Version - Family/Activities | -4.7 | 1.87 | ||||||||
| Parent Version - Social | -7.7 | 3.08 | ||||||||
| Parent Version - Daily Living Skills | -2.7 | 1.59 | ||||||||
| Child Report - Activities | -6.5 | 3.04 | ||||||||
| Child Report - School | -5.9 | 2.33 | ||||||||
| Child Report - Social | -3.8 | 1.17 | ||||||||
| COWS | Clinical Opiate Withdrawal Scale | Substance Use | Peak score (occurred about 30 min following injection) | 7.6 | ||||||
| CPSS-5 | Child PTSD Symptom Scale for DSM-5 | PTSD | Intrusion - Interview | -3.24 | 1.47 | |||||
| Avoidance - Interview | -1.89 | 0.85 | ||||||||
| Changes in cognition and mood - Interview | -6.01 | 2.36 | ||||||||
| Increased arousal and hyperactivity - Interview | -4.55 | 1.81 | ||||||||
| Intrusion - Self report | -2.59 | 0.92 | ||||||||
| Avoidance - Self-report | -0.76 | 0.93 | ||||||||
| Changes in cognition and mood - Self-report | -4.82 | 2.68 | ||||||||
| Arousal and hyperactivity | -2.03 | 2.16 | ||||||||
| CRAFFT + N | Car, Relax, Alone, Forget, Friends, Trouble | Risk/Impulse | Total | -2.50 | 0.81 | |||||
| CSHQ | Children's Sleep Habits Questionnaire | Sleep | Bedtime resistance | 2.45 | 10.84 | 7.89 | 2.94 | 2.47 | 1.50 | 1.40 |
| Sleep onset delay | 0.04 | 2.31 | 1.46 | 1.89 | 1.59 | 0.97 | 0.36 | |||
| Sleep duration | 0.98 | 5.17 | 3.90 | 1.68 | 1.42 | 0.86 | 0.77 | |||
| Sleep anxiety | 2.21 | 7.79 | 5.71 | 2.95 | 2.48 | 1.50 | 1.00 | |||
| Night wakings | 2.49 | 5.29 | 4.29 | 2.48 | 2.08 | 1.26 | 0.65 | |||
| Parasomnias | 6.16 | 10.61 | 9.14 | 3.27 | 2.75 | 1.67 | 1.00 | |||
| Sleep-disordered breathing | -0.37 | 4.50 | 3.53 | 0.93 | 0.78 | 0.47 | 0.93 | |||
| Daytime sleepiness | 5.21 | 15.24 | 10.70 | 4.68 | 3.94 | 2.39 | 1.55 | |||
| CSQ-8 | Client Satisfaction Questionnaire - 8 | Evidence-Based Assessment/Clinical Practice | Total | 16.86 | 1.61 | |||||
| DASA-YV | Dynamic Appraisal of Situational Aggression - Youth Version | Aggression | Total | -2.55 | 0.57 | |||||
| DES | Dissociative Experiences Scale | Dissociation | Total | 5 | 39.11 | 26.85 | 8.72 | 7.34 | 4.45 | 8.51 |
| Amneia | -19 | 28.6 | 15.46 | 12.23 | 10.30 | 6.23 | 10.22 | |||
| Depersonalization | -4 | 30.07 | 19.34 | 18.80 | 15.83 | 9.59 | 9.73 | |||
| Absorption | -2 | 45.12 | 28.69 | 18.40 | 15.49 | 9.39 | 8.82 | |||
| EBPAS | Evidence-Based Practice Attitude Scale | Evidence-Based Assessment/Clinical Practice | Appeal | 1.56 | 0.24 | |||||
| Requirements | 0.71 | 0.31 | ||||||||
| Openness | 0.99 | 0.27 | ||||||||
| Divergence | 0.24 | |||||||||
| ECBI | Eyeberg Child Behavior Inventory | Intensity | 66.2 | 155.4 | 116.39 | 22.57 | 19.00 | 11.51 | 8.49 | |
| Problem | -2 | 19.7 | 10.84 | 5.64 | 4.75 | 2.88 | 4.30 | |||
| EDE-Q | Eating Disorder Examination Questionnaire | Eating Disorders | Restraint | -0.5 | 3.83 | 1.84 | 1.53 | 1.29 | 0.78 | 0.69 |
| Eating concerns | 0.6 | 2.27 | 1.64 | 1.41 | 1.19 | 0.72 | 0.58 | |||
| Weight concerns | 1.9 | 4.26 | 2.98 | 1.10 | 0.93 | 0.56 | 0.60 | |||
| Shape concern | 2.6 | 5.04 | 3.66 | 0.92 | 0.78 | 0.47 | 0.64 | |||
| EDS | Everyday Discrimination Scale (Short Version) | Life Events/Health | Discrimination frequency | 1.60 | 0.23 | |||||
| Attributed to race/ethnicity | 1.24 | 0.19 | ||||||||
| ERC | Emotion Regulation Checklist | PTSD | Emotional Regulation - Preschool | 26.96 | 0.84 | |||||
| Liability/Negativity - Preschool | 37.52 | 1.47 | ||||||||
| Emotional Regulation - Elementary | 27.72 | 0.91 | ||||||||
| Liability/Negativity - Elementary | 10.28 | 1.36 | ||||||||
| FAD | Family Assessment Device | Family Functioning | Problem solving | 1.47 | 2.72 | 2.19 | 0.59 | 0.50 | 0.30 | 0.22 |
| Communication | 1.52 | 2.81 | 2.20 | 0.56 | 0.47 | 0.29 | 0.20 | |||
| Roles | 1.52 | 2.9 | 2.26 | 0.53 | 0.45 | 0.27 | 0.18 | |||
| Affective responsiveness | 1.14 | 2.91 | 2.12 | 0.60 | 0.50 | 0.30 | 0.26 | |||
| Affective involvement | 1.33 | 2.86 | 2.11 | 0.56 | 0.47 | 0.29 | 0.22 | |||
| Behavior control | 1.13 | 2.25 | 1.77 | 0.51 | 0.43 | 0.26 | 0.18 | |||
| General functioning | 1.33 | 2.62 | 2.02 | 0.36 | 0.30 | 0.18 | 0.23 | |||
| FASA | Family Accommodation Scale - Anxiety | Anxiety | Total | -3.34 | 3.15 | |||||
| Participation | -1.22 | 1.86 | ||||||||
| Modification | -4.6 | 1.73 | ||||||||
| Distress | -1.1 | 0.50 | ||||||||
| Consequences | -2.36 | 1.39 | ||||||||
| FIRM | Family Index of Risk for Mood | Bipolar/Mania, Depression | Nonbipolar | -3.00 | 1.13 | |||||
| Bipolar | -2.40 | 1.34 | ||||||||
| Total | -2.90 | 1.17 | ||||||||
| FOCI | Florida Obsessive-Compulsive Inventory | OCD | Total | 5.72 | 10.52 | 8.19 | 3.55 | 2.99 | 1.81 | 1.71 |
| C-FOCI | Children's Florida Obsessive-Compulsive Inventory | OCD | Symptom Checklist | -0.86 | 4.55 | 4.55 | 1.25 | |||
| Severity Scale | 3.08 | 5.3 | 4.59 | 3.55 | 2.99 | 1.81 | 1.59 | |||
| GAD-7 | Generalized Anxiety Disorder-7 | Anxiety | Total | 5.00 | 14.5 | 9.70 | 3.72 | 3.13 | 1.90 | 2.38 |
| GIDYQ-AA | Gender Identity/Gender Dysphoria Questionnaire for Adolescents and Adults | Gender Dysphoria | Heterosexual | 5.18 | 0.06 | |||||
| Nonheterosexual | 5.37 | 0.15 | ||||||||
| Gender Identity Patients | 1.51 | 0.17 | ||||||||
| HHS | Healthy Habits Survey | Life Events/Health | Total | |||||||
| HSQ | Home Situations Questionnaire | Life Events/Health | Problem Situations* (Not technically a subscale) | 9.68 | 1.14 | |||||
| Mean Severity* (Not technically a subscale) | 4.62 | 0.52 | ||||||||
| HSQ-ASD | Home Situations Questionnaire - Autism Spectrum Disorder | Autism | Socially Inflexible | 9.18 | 7.21 | |||||
| Demand Specific | -2.13 | 7.39 | ||||||||
| Total | 16.22 | 12.98 | ||||||||
| ISI | Insomnia Severity Index | Sleep | Total | 11.5 | 1.45 | |||||
| ISQ | Insomnia Symptom Questionnaire | Sleep | Total | |||||||
| LDQ | Leeds Dependence Questionnaire | Substance Use | Total | 1.57 | 2.91 | |||||
| MDQ | Mood Disorder Questionnaire | Bipolar/Mania, Depression | Bipolar I* (Not technically a subscale) | 5.71 | 0.95 | |||||
| Bipolar II* (Not technically a subscale) | 4.34 | 1.02 | ||||||||
| Unipolar | -1.64 | 1.00 | ||||||||
| MOAS | Modified Overt Aggression Scale | Conduct Problems | Verbal Aggression | -7.51 | 2.41 | |||||
| Verbal Aggression* (Repeat?) | -2.37 | 0.66 | ||||||||
| Property Aggression | -2.72 | 0.89 | ||||||||
| Autoaggression | -2.27 | 0.55 | ||||||||
| Physical Aggression Against Others | -2.79 | 0.79 | ||||||||
| MSI-BPD | McLean Screening Instrument for Borderline Personality Disorder | Borderline Personality Disorder | Total | -0.35 | 10.34 | 4.49 | 4.14 | 3.48 | 2.11 | 1.48 |
| NAS | Novaco Anger Scale | Conduct Problems | Cognitive | 20.2 | 33.8 | 28.36 | 5.19 | 4.36 | 2.65 | 2.29 |
| Arousal | 19.6 | 34.3 | 28.25 | 5.39 | 4.54 | 2.75 | 2.59 | |||
| Behavioral | 13.5 | 30.9 | 24.66 | 4.67 | 3.93 | 2.38 | 2.75 | |||
| Anger Regulation | -7.7 | 33.9 | 27.5 | 10.50 | 8.84 | 5.36 | 5.93 | |||
| OCI-R | Obsessive Compulsive Inventory - Revised | OCD | Washing | -4.27 | 7.41 | 3.12 | 3.15 | 2.65 | 1.61 | 1.76 |
| Checking | -2.89 | 8.03 | 3.68 | 3.59 | 3.02 | 1.83 | 1.64 | |||
| Ordering | -3.24 | 10.46 | 4.56 | 3.05 | 2.57 | 1.56 | 1.77 | |||
| Obsessing | -0.45 | 8.3 | 4.67 | 3.10 | 2.61 | 1.58 | 1.66 | |||
| Hoarding | -4.07 | 9.75 | 4.12 | 2.82 | 2.37 | 1.44 | 1.66 | |||
| Neutralizing | -4.44 | 6.22 | 2.32 | 3.31 | 2.79 | 1.69 | 1.56 | |||
| PAM | Physical Activity Monitoring | Life Events/Health | Total | |||||||
| PCQ | Parental Competence Questionnaire | Family Functioning | Parental Efficacy | 19.27 | 17.62 | |||||
| Parental Responsibility | 32.6 | 30.43 | ||||||||
| Child Control | 16.29 | 14.37 | ||||||||
| Fate/Chance | 22.51 | 21.55 | ||||||||
| Parental Control | 31.44 | 26.63 | ||||||||
| PHQ-8 | Patient Health Questionnaire - 8 items | Depression | Total | 10.47 | 1.36 | |||||
| PHQ-9 | Patient Health Questionnaire - 9 items | Depression, Self Injury | Total | -0.77 | 9.95 | 6.14 | 4.91 | 4.14 | 2.51 | 2.58 |
| PHQ-15 | Patient Health Questionnaire - 15 items | Depression | Total | -0.29 | 12 | 7.10 | 5.03 | 4.24 | 2.57 | 2.63 |
| PQ-B | Prodromal Questionnaire - Brief Version (PQ-B) | Schizophrenia | Total | -22.6 | 8.87 | |||||
| Symptom Frequency | 13 | 1.48 | ||||||||
| Distress | -5.47 | 2.68 | 2.53 | 1.79 | 1.51 | 0.91 | 1.64 | |||
| PSC-17 | Pediatric Symptom Checklist | Broad Psychopathology | Attention | -2.00 | 0.99 | |||||
| Externalizing | -2.50 | 1.13 | ||||||||
| Internalizing | -1.80 | 0.99 | ||||||||
| PSOC-R | The Parenting Sense of Competence Scale: Updating a Classic | Family Functioning | Efficacy | 22.44 | 2.92 | |||||
| Satisfaction | 28.25 | 1.77 | ||||||||
| SCARED-41 | Screen for Child Anxiety Related Emotional Disorders | Anxiety | Total | -6.8 | 5.45 | |||||
| Panic Disorder | -4.37 | 1.75 | ||||||||
| Generalized Anxiety Disorder | -2.87 | 1.68 | ||||||||
| Separation Anxiety Disorder | -3.51 | 1.33 | ||||||||
| Social Anxiety Disorder | -2.23 | 1.35 | ||||||||
| School Avoidance | -1.83 | 0.77 | ||||||||
| SCI | Sleep Condition Indicator | Sleep | Total | 3.11 | 2.10 | |||||
| SCOFF | Make Self Sick, Loss of Control, One-month Weight Loss, Believe am Fat, and Food Dominates Life | Eating Disorders | Total | -1.52 | 0.49 | |||||
| SCORE-15 | Systemic Clinical Outcome and Routine Evaluation - 15 item | Family Functioning | Total | 22.68 | 54.65 | 40.37 | 7.90 | 6.65 | 4.03 | 6.44 |
| Strengths and Adaptability Subscale | ||||||||||
| Overwhelmed by Difficulties Subscale | ||||||||||
| Disrupted Communication Subscale | ||||||||||
| SHI | Self-Harm Inventory | Self Injury | Total | 1.01 | 12.36 | 7.36 | 4.64 | 3.90 | 2.37 | 2.06 |
| SMFQ | Short Mood and Feelings Questionnaire | Depression | Total | 0.10 | 11.00 | 6.91 | 4.46 | 3.76 | 2.28 | 2.47 |
| SOCS | Short Obsessive-Compulsive Disorder Screener | OCD | Total | 1.26 | 11.3 | 6.55 | 3.79 | 3.19 | 1.93 | 1.50 |
| UGDS-GS | Utrecht Gender Dysphoria Scale - Gender Spectrum | Gender Dysphoria | Overall | 72.81 | 5.00 | |||||
| Dysphoria | 55.07 | 3.94 | ||||||||
| Gender Affirmation | 17.57 | 1.03 | ||||||||
| VADPRS | Vanderbilt ADHD Diagnostic Parent Rating Scale | Broad Psychopathology | Inattention | 24.91 | 2.55 | |||||
| Hyperactivity/impulsivity | 23.52 | 2.56 | ||||||||
| Conduct/oppositional | 29.42 | 3.39 | ||||||||
| Anxiety/depression | 15.27 | 1.86 | ||||||||
| VADTRS | Vanderbilt ADHD Diagnostic Teacher Rating Scale | Broad Psychopathology | Inattention | 0.82 | 22.61 | 6.69 | 2.45 | 2.06 | 1.25 | 2.85 |
| Hyperactive/impulsive | -1.72 | 19.45 | 4.99 | 2.88 | 2.42 | 1.47 | 2.71 | |||
| Conduct/oppositional | -3.99 | 12.95 | 2.15 | 2.66 | 2.24 | 1.36 | 2.10 | |||
| Anxiety/depression | -2.39 | 8.77 | 1.35 | 2.13 | 1.80 | 1.09 | 1.32 | |||
| YP-CORE | Young Person's Clinical Outcomes in Routine Evaluation | Broad Psychopathology | Total | 4.00 | 24.00 | 12.14 | 9.17 | 7.72 | 4.68 | 3.70 |
Will be updated as RISE internship continues!
References
edit- ↑ Beck, AT (1988). "Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation.". Clinical Psychology Review 8 (1). http://www.sciencedirect.com/science/article/pii/0272735888900505. Retrieved 10 February 2014.